{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:41:43Z","timestamp":1794613303608,"version":"4.9.1"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ejmech.2021.113519","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T11:55:19Z","timestamp":1620129319000},"page":"113519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Arsenic compounds: The wide application and mechanisms applied in acute promyelocytic leukemia and carcinogenic toxicology"],"prefix":"10.1016","volume":"221","author":[{"given":"Guangzhi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuchunyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingcai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113519_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fcell.2018.00099","article-title":"Editorial: molecular mechanisms of metalloid transport, toxicity and tolerance","volume":"6","author":"Bienert","year":"2018","journal-title":"Front. Cell. Develop. Biol."},{"key":"10.1016\/j.ejmech.2021.113519_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-4274(02)00084-X","article-title":"Arsenic toxicity and potential mechanisms of action","volume":"133","author":"Hughes","year":"2002","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejmech.2021.113519_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.scitotenv.2018.01.079","article-title":"Arsenic characteristics in the terrestrial environment in the vicinity of the Shimen realgar mine, China","volume":"626","author":"Yang","year":"2018","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.ejmech.2021.113519_bib4","first-page":"205","article-title":"Arsenite as the probable active species in the human carcinogenicity of arsenic: mouse micronucleus assays on Na and K arsenite, orpiment, and Fowler's solution","volume":"95","author":"Tinwell","year":"1991","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ejmech.2021.113519_bib5","series-title":"The Role of Biomethylation in Toxicity and Carcinogenicity of Arsenic: a Research Update","first-page":"767","author":"St\u00fdblo","year":"2002"},{"key":"10.1016\/j.ejmech.2021.113519_bib6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00775-018-1537-9","article-title":"Arsenic trioxide: insights into its evolution to an anticancer agent","volume":"23","author":"Hoonjan","year":"2018","journal-title":"J.\u00a0Biol. Inorg. Chem. : JBIC : Publ. Soc. Biol. Inorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113519_bib7","first-page":"3","article-title":"Arsenic: a beneficial therapeutic poison - a historical overview","volume":"35","author":"Thomas","year":"2009","journal-title":"Adler Mus. Bull."},{"key":"10.1016\/j.ejmech.2021.113519_bib8","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.leukres.2004.01.011","article-title":"The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future","volume":"28","author":"Evens","year":"2004","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ejmech.2021.113519_bib9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11864-012-0223-3","article-title":"Role of arsenic trioxide in acute promyelocytic leukemia","volume":"14","author":"Iland","year":"2013","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.ejmech.2021.113519_bib10","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/annonc\/mdw171","article-title":"Current management of newly diagnosed acute promyelocytic leukemia","volume":"27","author":"Cicconi","year":"2016","journal-title":"Ann. Oncol. : Off. J. European Soc. Med. Oncol."},{"key":"10.1016\/j.ejmech.2021.113519_bib11","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.1111\/jcmm.13917","article-title":"PML-RAR\u03b1 interferes with erythropoiesis by repressing LMO2 in acute promyelocytic leukaemia","volume":"22","author":"Yang","year":"2018","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.ejmech.2021.113519_bib12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0092-8674(93)80044-F","article-title":"The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells","volume":"74","author":"Grignani","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113519_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ccr.2010.06.003","article-title":"PML\/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3","volume":"18","author":"Jeanne","year":"2010","journal-title":"Canc. Cell"},{"key":"10.1016\/j.ejmech.2021.113519_bib14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/sj.leu.2401650","article-title":"Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia","volume":"14","author":"Cai","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2021.113519_bib15","series-title":"Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies","first-page":"11","author":"Noguera","year":"2019"},{"key":"10.1016\/j.ejmech.2021.113519_bib16","first-page":"3893","article-title":"Mechanisms of action of arsenic trioxide","volume":"62","author":"Miller","year":"2002","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113519_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mrfmmm.2003.07.009","article-title":"Mechanism of arsenic carcinogenesis: an integrated approach","volume":"533","author":"Rossman","year":"2003","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ejmech.2021.113519_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/B:MCBI.0000007261.04684.78","article-title":"Molecular mechanisms of arsenic carcinogenesis","volume":"255","author":"Huang","year":"2004","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejmech.2021.113519_bib19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/B:MCBI.0000007262.26044.e8","article-title":"Oxidative mechanism of arsenic toxicity and carcinogenesis","volume":"255","author":"Shi","year":"2004","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejmech.2021.113519_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/theoncologist.6-suppl_2-1","article-title":"Introduction: the history of arsenic trioxide in cancer therapy","author":"Antman","year":"2001","journal-title":"Oncol."},{"key":"10.1016\/j.ejmech.2021.113519_bib21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jep.2011.03.071","article-title":"The medicinal use of realgar (As\u2084S\u2084) and its recent development as an anticancer agent","volume":"135","author":"Wu","year":"2011","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2021.113519_bib22","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jep.2016.07.053","article-title":"Plants used to treat diabetes in Sri Lankan Siddha Medicine - an ethnopharmacological review of historical and modern sources","volume":"198","author":"Sathasivampillai","year":"2017","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2021.113519_bib23","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3892\/ijo.2011.1276","article-title":"Realgar-induced apoptosis and differentiation in all-trans retinoic acid (ATRA)-sensitive NB4 and ATRA-resistant MR2 cells","volume":"40","author":"Chen","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2021.113519_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/jat.1649","article-title":"Arsenic: toxicity, oxidative stress and human disease","volume":"31","author":"Jomova","year":"2011","journal-title":"J.\u00a0Appl. Toxicol. : JAT"},{"key":"10.1016\/j.ejmech.2021.113519_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/10408440500534230","article-title":"Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment","volume":"36","author":"Cohen","year":"2006","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113519_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10534-011-9489-3","article-title":"Arsenic trioxide versus tetraarsenic oxide in biomedical research: misunderstandings and misinterpretations","volume":"25","author":"Slejkovec","year":"2012","journal-title":"Biometals: Int. J. Role Metal Ions Biol. Biochem. Med."},{"key":"10.1016\/j.ejmech.2021.113519_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s11671-016-1228-9","article-title":"Probing sub-atomistic free-volume imperfections in dry-milled nanoarsenicals with PAL spectroscopy","volume":"11","author":"Shpotyuk","year":"2016","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.ejmech.2021.113519_bib28","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3390\/toxins2061568","article-title":"Arsenic in cancer treatment: challenges for application of realgar nanoparticles (a minireview)","volume":"2","author":"Bal\u00e1\u017e","year":"2010","journal-title":"Toxins"},{"key":"10.1016\/j.ejmech.2021.113519_bib29","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1039\/C9CP06298J","article-title":"Orpiment under compression: metavalent bonding at high pressure","volume":"22","author":"Cuenca-Gotor","year":"2020","journal-title":"Phys. Chem. Chem. Phys. : Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.ejmech.2021.113519_bib30","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1021\/jp102391a","article-title":"Bond paths and van der Waals interactions in orpiment, As2S3","volume":"114","author":"Gibbs","year":"2010","journal-title":"J.\u00a0Phys. Chem. A"},{"key":"10.1016\/j.ejmech.2021.113519_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.142062","article-title":"Arsenic in waters, soils, sediments, and biota from Mexico: an environmental review","volume":"752","author":"Osuna-Mart\u00ednez","year":"2021","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.ejmech.2021.113519_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.aca.2011.12.001","article-title":"Arsenic speciation in edible alga samples by microwave-assisted extraction and high performance liquid chromatography coupled to atomic fluorescence spectrometry","volume":"714","author":"Garc\u00eda-Salgado","year":"2012","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ejmech.2021.113519_bib33","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.fct.2012.05.010","article-title":"Daily intake of inorganic arsenic and some organic arsenic species of Japanese subjects","volume":"50","author":"Oguri","year":"2012","journal-title":"Food Chem. Toxicol. : Int. J. Publ. Br. Industrial Biol. Res. Assoc."},{"key":"10.1016\/j.ejmech.2021.113519_bib34","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1021\/es505358c","article-title":"Birnessite (\u03b4-MnO2) mediated degradation of organoarsenic feed additive p-arsanilic acid","volume":"49","author":"Wang","year":"2015","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.ejmech.2021.113519_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.02050-19","article-title":"N-hydroxyarylamine -acetyltransferases catalyze acetylation of 3-amino-4-hydroxyphenylarsonic acid in the 4-hydroxy-3-nitrobenzenearsonic acid transformation pathway of sp. strain CZ-1","volume":"86","author":"Huang","year":"2020","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ejmech.2021.113519_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8080260","article-title":"Plasmodium falciparumOrganoarsenic compounds with in\u00a0vitro activity against the malaria parasite","volume":"8","author":"Basova","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2021.113519_bib37","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1080\/09593330.2015.1025105","article-title":"Determination of para-arsanilic acid with improved diazotization reaction using differential pulse cathodic stripping voltammetry in aqueous system","volume":"36","author":"Misni","year":"2015","journal-title":"Environ. Technol."},{"key":"10.1016\/j.ejmech.2021.113519_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20143418","article-title":"Arsenic neurotoxicity in humans","volume":"20","author":"Mochizuki","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113519_bib39","doi-asserted-by":"crossref","first-page":"25736","DOI":"10.18632\/oncotarget.15106","article-title":"Oncogenomic disruptions in arsenic-induced carcinogenesis","volume":"8","author":"Sage","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2021.113519_bib40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0300-483X(02)00285-8","article-title":"Mechanisms of arsenic biotransformation","author":"Vahter","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.ejmech.2021.113519_bib41","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-015-0143-3","article-title":"Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9","volume":"8","author":"Chau","year":"2015","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.ejmech.2021.113519_bib42","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/toxsci\/kfq141","article-title":"Polynucleotide phosphorylase and mitochondrial ATP synthase mediate reduction of arsenate to the more toxic arsenite by forming arsenylated analogues of ADP and ATP","volume":"117","author":"N\u00e9meti","year":"2010","journal-title":"Toxicol. Sci. : Off. J. Soc. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113519_bib43","doi-asserted-by":"crossref","first-page":"32700","DOI":"10.1074\/jbc.M404912200","article-title":"Arsenic transport by the human multidrug resistance protein 1 (MRP1\/ABCC1). Evidence that a tri-glutathione conjugate is required","volume":"279","author":"Leslie","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113519_bib44","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1006\/taap.2001.9226","article-title":"Determination of trivalent methylated arsenicals in biological matrices","volume":"174","author":"Del Razo","year":"2001","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113519_bib45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/taap.1999.8872","article-title":"Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes","volume":"163","author":"Petrick","year":"2000","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113519_bib46","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ctrv.2007.05.001","article-title":"Arsenical-based cancer drugs","volume":"33","author":"Dilda","year":"2007","journal-title":"Canc. Treat Rev."},{"key":"10.1016\/j.ejmech.2021.113519_bib47","first-page":"3812","article-title":"Dual effects of arsenic trioxide on tumor cells and the potential underlying mechanisms","volume":"16","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejmech.2021.113519_bib48","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/jcp.22397","article-title":"Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells","volume":"226","author":"Eguchi","year":"2011","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.ejmech.2021.113519_bib49","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijpharm.2017.01.031","article-title":"RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma","volume":"519","author":"Fei","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2021.113519_bib50","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.biortech.2013.01.106","article-title":"Microbial synthesis of poly-3-hydroxybutyrate and its application as targeted drug delivery vehicle","volume":"145","author":"Althuri","year":"2013","journal-title":"Bioresour. Technol."},{"key":"10.1016\/j.ejmech.2021.113519_bib51","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/s41598-017-18932-4","article-title":"Targeting murine leukemic stem cells by antibody functionalized mesoporous silica nanoparticles","volume":"8","author":"Mandal","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2021.113519_bib52","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.nano.2013.08.007","article-title":"Combination of siRNA-directed Kras oncogene silencing and arsenic-induced apoptosis using a nanomedicine strategy for the effective treatment of pancreatic cancer","volume":"10","author":"Zeng","year":"2014","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ejmech.2021.113519_bib53","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0022-3565(24)38961-X","article-title":"Sensitivity of myelomonocytic leukemia cells to arsenite-induced cell cycle disruption, apoptosis, and enhanced differentiation is dependent on the inter-relationship between arsenic concentration, duration of treatment, and cell cycle phase","volume":"295","author":"McCabe","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2021.113519_bib54","article-title":"Traditional Chinese medicine containing arsenic treated MDS patients effectively through regulating aberrant hypomethylation, evidence-based complementary and alternative medicine","volume":"2020","author":"Zhou","year":"2020","journal-title":"eCAM"},{"key":"10.1016\/j.ejmech.2021.113519_bib55","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.taap.2006.12.005","article-title":"Bioaccessibility and excretion of arsenic in niu Huang jie du pian pills","volume":"222","author":"Koch","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113519_bib56","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejps.2006.05.002","article-title":"Evaluation of the in\u00a0vitro activity and in\u00a0vivo bioavailability of realgar nanoparticles prepared by cryo-grinding","volume":"29","author":"Wu","year":"2006","journal-title":"Eur. J. Pharmaceut. Sci. : Off. J. European Federat. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2021.113519_bib57","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.2147\/IJN.S21373","article-title":"Effect of size and processing method on the cytotoxicity of realgar nanoparticles in cancer cell lines","volume":"6","author":"Zhao","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejmech.2021.113519_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.110683","article-title":"Preparation of AsS\/FeO nanosuspensions and in-vitro verification of their anticancer activity","volume":"110","author":"Buj\u0148\u00e1kov\u00e1","year":"2020","journal-title":"Mater. Sci. Eng. C, Mater. Biol. Appl."},{"key":"10.1016\/j.ejmech.2021.113519_bib59","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1124\/jpet.108.139543","article-title":"Mineral arsenicals in traditional medicines: orpiment, realgar, and arsenolite","volume":"326","author":"Liu","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2021.113519_bib60","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1166\/jnn.2007.145","article-title":"Preparation of orpiment nanoparticles and their cytotoxic effect on cultured leukemia K562 cells","volume":"7","author":"Lin","year":"2007","journal-title":"J.\u00a0Nanosci. Nanotechnol."},{"key":"10.1016\/j.ejmech.2021.113519_bib61","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s13318-010-0009-6","article-title":"Speciation of arsenic in urine following intravenous administration of arsthinol in mice","volume":"35","author":"Ajana","year":"2010","journal-title":"Eur. J. Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2021.113519_bib62","doi-asserted-by":"crossref","first-page":"16429","DOI":"10.1007\/s11356-017-9242-8","article-title":"Soil calcium significantly promotes uptake of inorganic arsenic by garland chrysanthemum (ChrysanthemumL coronarium) fertilized with chicken manure bearing roxarsone and its metabolites","volume":"24","author":"Yao","year":"2017","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.ejmech.2021.113519_bib63","doi-asserted-by":"crossref","first-page":"12017","DOI":"10.1007\/s11356-020-07808-2","article-title":"Remediation of organic arsenic contaminants with heterogeneous Fenton process mediated by SiO-coated nano zero-valent iron","volume":"27","author":"Lv","year":"2020","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.ejmech.2021.113519_bib64","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.talanta.2013.07.066","article-title":"Determination of the trypanocidal drug melarsoprol and its conversion products in biological fluids with HPLC-ICPMS\/ESMS","volume":"116","author":"Raber","year":"2013","journal-title":"Talanta"},{"key":"10.1016\/j.ejmech.2021.113519_bib65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/01480545.2013.806532","article-title":"Arsanilic acid causes apoptosis and oxidative stress in rat kidney epithelial cells (NRK-52e cells) by the activation of the caspase-9 and -3 signaling pathway","volume":"37","author":"Lu","year":"2014","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113519_bib66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1634\/theoncologist.6-suppl_2-3","article-title":"History of the development of arsenic derivatives in cancer therapy","author":"Waxman","year":"2001","journal-title":"Oncol."},{"key":"10.1016\/j.ejmech.2021.113519_bib67","first-page":"366","article-title":"Anticancer efficacies of arsenic disulfide through apoptosis induction, cell cycle arrest, and pro-survival signal inhibition in human breast cancer cells","volume":"8","author":"Zhao","year":"2018","journal-title":"Am. J. Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113519_bib68","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1073\/pnas.0712365105","article-title":"Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia","volume":"105","author":"Wang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2021.113519_bib69","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/cncr.29852","article-title":"The evolution of arsenic in the treatment of acute promyelocytic leukemia and other myeloid neoplasms: moving toward an effective oral, outpatient therapy","volume":"122","author":"Falchi","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ejmech.2021.113519_bib70","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jep.2017.08.037","article-title":"A\u00a0review of cinnabar (HgS) and\/or realgar (AsS)-containing traditional medicines","volume":"210","author":"Liu","year":"2018","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2021.113519_bib71","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/leu.2016.227","article-title":"Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia","volume":"30","author":"Ganesan","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2021.113519_bib72","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/leu.2011.245","article-title":"Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia","volume":"26","author":"Lengfelder","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2021.113519_bib73","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1084\/jem.20131121","article-title":"Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia","volume":"210","author":"Dos Santos","year":"2013","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ejmech.2021.113519_bib74","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1371\/journal.pmed.0020012","article-title":"Retinoic acid and arsenic for treating acute promyelocytic leukemia","volume":"2","author":"Zhou","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejmech.2021.113519_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20163895","article-title":"The SUMO pathway in hematomalignancies and their response to therapies","volume":"20","author":"Boulanger","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113519_bib76","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/s41375-018-0338-z","article-title":"The genetics and clinical characteristics of children morphologically diagnosed as acute promyelocytic leukemia","volume":"33","author":"Zhao","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2021.113519_bib77","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/nrm2277","article-title":"Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies","volume":"8","author":"Bernardi","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113519_bib78","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1083\/jcb.201305148","article-title":"Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins","volume":"204","author":"Sahin","year":"2014","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113519_bib79","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1182\/blood.V95.9.2748.009k31a_2748_2752","article-title":"Role of SUMO-1-modified PML in nuclear body formation","volume":"95","author":"Zhong","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2021.113519_bib80","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/ncb1717","article-title":"Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4\/ubiquitin-mediated pathway","volume":"10","author":"Lallemand-Breitenbach","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113519_bib81","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/emboj\/17.1.61","article-title":"Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus","volume":"17","author":"M\u00fcller","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2021.113519_bib82","first-page":"5468","article-title":"Inhibition of promyelocytic leukemia (PML)\/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid","volume":"61","author":"Mologni","year":"2001","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113519_bib83","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/ncb1716","article-title":"RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation","volume":"10","author":"Tatham","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113519_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044949","article-title":"Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms","volume":"7","author":"Maroui","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2021.113519_bib85","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1182\/blood-2011-10-388496","article-title":"The arsenic-based cure of acute promyelocytic leukemia promotes cytoplasmic sequestration of PML and PML\/RARA through inhibition of PML body recycling","volume":"120","author":"L\u00e5ng","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2021.113519_bib86","first-page":"358","article-title":"Arsenic trioxide selectively induces early and extensive apoptosis via the APO2\/caspase-8 pathway engaging the mitochondrial pathway in myeloma cells with mutant p53","volume":"2","author":"Akay","year":"2003","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejmech.2021.113519_bib87","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/B978-0-12-152824-9.50015-0","article-title":"Selenium--glutathione peroxidase: properties and synthesis","volume":"24","author":"Tappel","year":"1984","journal-title":"Curr. Top. Cell. Regul."},{"key":"10.1016\/j.ejmech.2021.113519_bib88","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ijc.24341","article-title":"Downregulation of the c-MYC target gene, peroxiredoxin III, contributes to arsenic trioxide-induced apoptosis in acute promyelocytic leukemia","volume":"125","author":"Vivas-Mej\u00eda","year":"2009","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.ejmech.2021.113519_bib89","doi-asserted-by":"crossref","first-page":"29714","DOI":"10.1074\/jbc.M113.473470","article-title":"Molecular basis for the resistance of human mitochondrial 2-Cys peroxiredoxin 3 to hyperoxidation","volume":"288","author":"Haynes","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113519_bib90","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2478\/s11658-006-0041-3","article-title":"Current concepts in apoptosis: the physiological suicide program revisited","volume":"11","author":"Chowdhury","year":"2006","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.ejmech.2021.113519_bib91","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.freeradbiomed.2016.07.029","article-title":"Mitochondrial HO signaling is controlled by the concerted action of peroxiredoxin III and sulfiredoxin: linking mitochondrial function to circadian rhythm","volume":"99","author":"Rhee","year":"2016","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.ejmech.2021.113519_bib92","first-page":"5922","article-title":"Identification of c-myc responsive genes using rat cDNA microarray","volume":"60","author":"Guo","year":"2000","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113519_bib93","doi-asserted-by":"crossref","first-page":"7163","DOI":"10.3390\/ijms12107163","article-title":"Mitochondrial peroxiredoxin III is a potential target for cancer therapy","volume":"12","author":"Song","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113519_bib94","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrm2245","article-title":"Autophagy: from phenomenology to molecular understanding in less than a decade","volume":"8","author":"Klionsky","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113519_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20143559","article-title":"Autophagy: new insights into mechanisms of action and resistance of treatment in acute promyelocytic leukemia","volume":"20","author":"Moosavi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113519_bib96","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1182\/blood-2010-01-261040","article-title":"Autophagy contributes to therapy-induced degradation of the PML\/RARA oncoprotein","volume":"116","author":"Isakson","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2021.113519_bib97","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1159\/000492646","article-title":"Autophagy and ubiquitin-mediated proteolytic degradation of PML\/rar\u03b1 fusion protein in matrine-induced differentiation sensitivity recovery of ATRA-resistant APL (NB4-LR1) cells: in\u00a0vitro and in\u00a0vivo studies, cellular physiology and biochemistry","volume":"48","author":"Wu","year":"2018","journal-title":"Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113519_bib98","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41419-017-0018-3","article-title":"Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2021.113519_bib99","first-page":"2103","article-title":"Induction of autophagic cell death in malignant glioma cells by arsenic trioxide","volume":"63","author":"Kanzawa","year":"2003","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113519_bib100","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1089\/ars.2010.3554","article-title":"Autophagy signaling through reactive oxygen species","volume":"14","author":"Huang","year":"2011","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejmech.2021.113519_bib101","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev-pharmtox-010818-021031","article-title":"Metals and mechanisms of carcinogenesis","volume":"59","author":"Chen","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113519_bib102","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1515\/reveh-2016-0025","article-title":"Epigenomic reprogramming in inorganic arsenic-mediated gene expression patterns during carcinogenesis","volume":"32","author":"Eckstein","year":"2017","journal-title":"Rev. Environ. Health"},{"key":"10.1016\/j.ejmech.2021.113519_bib103","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neuro.2016.02.002","article-title":"Toxicity mechanisms of arsenic that are shared with neurodegenerative diseases and cognitive impairment: role of oxidative stress and inflammatory responses","volume":"53","author":"Escudero-Lourdes","year":"2016","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ejmech.2021.113519_bib104","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0006-291X(90)91674-H","article-title":"Induction of DNA damage by dimethylarsine, a metabolite of inorganic arsenics, is for the major part likely due to its peroxyl radical","volume":"168","author":"Yamanaka","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113519_bib105","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.chemosphere.2016.10.025","article-title":"Arsenic and fluoride induce apoptosis, inflammation and oxidative stress in cultured human umbilical vein endothelial cells","volume":"167","author":"Ma","year":"2017","journal-title":"Chemosphere"},{"key":"10.1016\/j.ejmech.2021.113519_bib106","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/1091581816645797","article-title":"In\u00a0vivo and in\u00a0vitro arsenic exposition induces oxidative stress in anterior pituitary gland","volume":"35","author":"Ronchetti","year":"2016","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113519_bib107","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0168-9525(93)90089-Z","article-title":"Mutagenesis by 8-oxoguanine: an enemy within","volume":"9","author":"Grollman","year":"1993","journal-title":"Trends Genet. : TIG (Trends Genet.)"},{"key":"10.1016\/j.ejmech.2021.113519_bib108","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1523-1747.1999.00630.x","article-title":"The role of oxidative DNA damage in human arsenic carcinogenesis: detection of 8-hydroxy-2'-deoxyguanosine in arsenic-related Bowen's disease","volume":"113","author":"Matsui","year":"1999","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ejmech.2021.113519_bib109","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1383-5742(97)00035-5","article-title":"Analysis of a form of oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis","volume":"387","author":"Kasai","year":"1997","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ejmech.2021.113519_bib110","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1097\/JTO.0b013e3182a4dd8e","article-title":"Whole-genome sequencing analysis identifies a distinctive mutational spectrum in an arsenic-related lung tumor","volume":"8","author":"Martinez","year":"2013","journal-title":"J.\u00a0Thorac. Oncol. : Off. Publ. Int. Assoc. Study Lung Canc."},{"key":"10.1016\/j.ejmech.2021.113519_bib111","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1021\/tx900343d","article-title":"Arsenic-induced carcinogenesis--oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment","volume":"23","author":"Kitchin","year":"2010","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113519_bib112","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/mutage\/12.5.353","article-title":"Arsenite retards DNA break rejoining by inhibiting DNA ligation","volume":"12","author":"Lynn","year":"1997","journal-title":"Mutagenesis"},{"key":"10.1016\/j.ejmech.2021.113519_bib113","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1383-5742(97)00011-2","article-title":"Inhibition of poly(ADP-ribose) polymerase by arsenite","volume":"386","author":"Yager","year":"1997","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ejmech.2021.113519_bib114","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ijc.21195","article-title":"TP53 alterations and patterns of carcinogen exposure in a U.S. population-based study of bladder cancer","volume":"117","author":"Kelsey","year":"2005","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.ejmech.2021.113519_bib115","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5487\/TR.2018.34.4.311","article-title":"Substantial evidences indicate that inorganic arsenic is a genotoxic carcinogen: a review","volume":"34","author":"Roy","year":"2018","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.ejmech.2021.113519_bib116","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1289\/ehp.7224","article-title":"Association of chromosomal alterations with arsenite-induced tumorigenicity of human HaCaT keratinocytes in nude mice","volume":"112","author":"Chien","year":"2004","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ejmech.2021.113519_bib117","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.chemosphere.2012.07.021","article-title":"Mouse micronucleus assay as a surrogate to assess genotoxic potential of arsenic at its human reference dose","volume":"90","author":"Khan","year":"2013","journal-title":"Chemosphere"},{"key":"10.1016\/j.ejmech.2021.113519_bib118","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/mutage\/14.6.605","article-title":"Necrosis, apoptosis, cytostasis and DNA damage in human lymphocytes measured simultaneously within the cytokinesis-block micronucleus assay: description of the method and results for hydrogen peroxide","volume":"14","author":"Fenech","year":"1999","journal-title":"Mutagenesis"},{"key":"10.1016\/j.ejmech.2021.113519_bib119","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s00128-006-1013-z","article-title":"Micronuclei and chromosomal aberrations as biomarkers: a study in an arsenic exposed population in West Bengal, India","volume":"76","author":"Chakraborty","year":"2006","journal-title":"Bull. Environ. Contam. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113519_bib120","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0092-8674(01)00220-3","article-title":"Spontaneous DNA damage, genome instability, and cancer--when DNA replication escapes control","volume":"104","author":"Sch\u00e4r","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113519_bib121","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mrgentox.2013.11.001","article-title":"Arsenic is cytotoxic and genotoxic to primary human lung cells, Mutation research","volume":"760","author":"Xie","year":"2014","journal-title":"Genetic Toxicol. Environ. Mutagenesis"},{"key":"10.1016\/j.ejmech.2021.113519_bib122","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.yrtph.2018.09.010","article-title":"A\u00a0review on arsenic carcinogenesis: epidemiology, metabolism, genotoxicity and epigenetic changes","volume":"99","author":"Zhou","year":"2018","journal-title":"Regul. Toxicol. Pharmacol. : RTP (Regul. Toxicol. Pharmacol.)"},{"key":"10.1016\/j.ejmech.2021.113519_bib123","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/em.21987","article-title":"Dysregulation of DNA methylation induced by past arsenic treatment causes persistent genomic instability in mammalian cells","volume":"57","author":"Mauro","year":"2016","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.ejmech.2021.113519_bib124","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/hmg\/9.16.2395","article-title":"The DNA methyltransferases of mammals","volume":"9","author":"Bestor","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmech.2021.113519_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115212","article-title":"Arsenic induced epigenetic changes and relevance to treatment of acute promyelocytic leukemia and beyond","volume":"406","author":"Maimaitiyiming","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113519_bib126","doi-asserted-by":"crossref","first-page":"21493","DOI":"10.18632\/oncotarget.4085","article-title":"Analysis of the transcriptional regulation of cancer-related genes by aberrant DNA methylation of the cis-regulation sites in the promoter region during hepatocyte carcinogenesis caused by arsenic","volume":"6","author":"Miao","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2021.113519_bib127","doi-asserted-by":"crossref","first-page":"R546","DOI":"10.1016\/j.cub.2004.07.007","article-title":"Histones and histone modifications","volume":"14","author":"Peterson","year":"2004","journal-title":"Curr. Biol. : CB"},{"key":"10.1016\/j.ejmech.2021.113519_bib128","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/toxsci\/kfx292","article-title":"Differentially expressed mRNA targets of differentially expressed miRNAs predict changes in the TP53 Axis and carcinogenesis-related pathways in human keratinocytes chronically exposed to arsenic","volume":"162","author":"Al-Eryani","year":"2018","journal-title":"Toxicol. Sci. : Off. J. Soc. Toxicol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421003688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421003688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:26:50Z","timestamp":1759328810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421003688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":128,"alternative-id":["S0223523421003688"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113519","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arsenic compounds: The wide application and mechanisms applied in acute promyelocytic leukemia and carcinogenic toxicology","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113519","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113519"}}